Financhill
Back

Nxera Pharma 10K Form

Sell
30

SOLTF
Nxera Pharma

Last Price:
7.25
Seasonality Move:
5.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOLTF News And Ratings

See the #1 stock for the next 7 days that we like better than SOLTF

SOLTF Financial Statistics

Sales & Book Value

Annual Sales: $90.99M
Cash Flow: $24.21M
Price / Cash Flow: 0
Annual Sales: $4.77
Price / Book: 1.48

Profitability

EPS (TTM): -0.77740
Net Income (TTM): $-66.73M
Gross Margin: $68.88M
Return on Equity: -15.46%
Return on Assets: -6.93%

Nxera Pharma Earnings Forecast

Key Nxera Pharma Financial Ratios

  • The Gross Profit Margin over the past 19 years for SOLTF is 75.70%.
  • The Selling, General & Administrative Expenses for SOLTF have been equal to 78.06% of Gross Profit Margin.
  • The Research & Development expenses have been 78.92% of Revenue.
  • The Interest Expense is -34.69% of Operating Income.
  • The Net Earning history of SOLTF is -56.34% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 7 years.

Nxera Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SOLTF
Website: sosei.com

Debt

Debt-to-Equity Ratio: 0.96
Current Ratio: 4.11
Quick Ratio: 3.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOLTF Technical Analysis vs Fundamental Analysis

Sell
30
Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy or a Sell?

  • Nxera Pharma stock is rated a Sell
    The current Nxera Pharma [SOLTF] share price is $7.25. The Score for SOLTF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.